Medication Prescribing

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes

Q&As

chronic inflammation
chronic inflammation
Anniek M. van Roon, MD, PhD, on Single-Port Thoracoscopic Sympathicotomy in Raynaud Phenomenon
04/17/2020
Anniek M. van Roon, MD, PhD, answered our questions about the efficacy and feasibility of single-port thoracoscopic sympathicotomy among patients with treatment-resistant Raynaud phenomenon.
04/17/2020
chronic inflammation
chronic inflammation
Anniek M. van Roon, MD, PhD, on Single-Port Thoracoscopic Sympathicotomy in Raynaud Phenomenon
04/17/2020
Anniek M. van Roon, MD, PhD, answered our questions about the efficacy and feasibility of single-port thoracoscopic sympathicotomy among patients with treatment-resistant Raynaud phenomenon.
04/17/2020
chronic inflammation
chronic inflammation
Anniek M. van Roon, MD, PhD, on Single-Port Thoracoscopic Sympathicotomy in Raynaud Phenomenon
04/17/2020
Anniek M. van Roon, MD, PhD, answered our questions about the efficacy and feasibility of single-port thoracoscopic sympathicotomy among patients with treatment-resistant Raynaud phenomenon.
04/17/2020
Multiple Sclerosis
Multiple Sclerosis
Mahsa Dadar, PhD, on the Transformation of Diffusely Abnormal White Matter Regions into Focal White Matter Lesions in SPMS
04/16/2020
Mahsa Dadar, PhD, answers our questions about her new study that suggested diffusely abnormal white matter regions in the brain evolve into focal white matter lesions over time in secondary progressive...
04/16/2020
Multiple Sclerosis
Multiple Sclerosis
Mahsa Dadar, PhD, on the Transformation of Diffusely Abnormal White Matter Regions into Focal White Matter Lesions in SPMS
04/16/2020
Mahsa Dadar, PhD, answers our questions about her new study that suggested diffusely abnormal white matter regions in the brain evolve into focal white matter lesions over time in secondary progressive...
04/16/2020
Multiple Sclerosis
Multiple Sclerosis
Mahsa Dadar, PhD, on the Transformation of Diffusely Abnormal White Matter Regions into Focal White Matter Lesions in SPMS
04/16/2020
Mahsa Dadar, PhD, answers our questions about her new study that suggested diffusely abnormal white matter regions in the brain evolve into focal white matter lesions over time in secondary progressive...
04/16/2020
LDL Cholesterol
LDL Cholesterol
Pam R. Taub, MD, on a New Approach for Managing Lipids
04/15/2020
The FDA approved bempedoic acid for the lowering of LDL-C in February 2020. In this Q&A, Pam R. Taub, MD, provides insight into the novel therapy.
04/15/2020
LDL Cholesterol
LDL Cholesterol
Pam R. Taub, MD, on a New Approach for Managing Lipids
04/15/2020
The FDA approved bempedoic acid for the lowering of LDL-C in February 2020. In this Q&A, Pam R. Taub, MD, provides insight into the novel therapy.
04/15/2020
LDL Cholesterol
LDL Cholesterol
Pam R. Taub, MD, on a New Approach for Managing Lipids
04/15/2020
The FDA approved bempedoic acid for the lowering of LDL-C in February 2020. In this Q&A, Pam R. Taub, MD, provides insight into the novel therapy.
04/15/2020
opioids
opioids
Anh P. Nguyen, PhD, on How Family Exposure Affects Youth Opioid Overdose Risk
04/14/2020
Consultant360 reached out to lead study author Anh P. Nguyen, PhD, from the Kaiser Permanente Institute for Health Research, to discuss a recent study which examined how exposure to prescription opioids...
04/14/2020